Taken together with these findings, our resultssuggest that increased sensitivity to TOP2 inhibitors caused by mutations or defectsof ATM pathways leads to KMT2A rearrangement, ultimately resultingin the development of infant leukemia. This evidence concerns the gene KMT2A and leukemia.